AstraZeneca Archives - InnoHEALTH magazine

Beactica, BluSense Diagnostics and Optomed announced as winners of the prestigious Nordic Stars 2018 Award at NLSDays in Stockholm

September 13, 2018September 19, 2018 InnoHEALTH Editorial Team 0 Comments affordable infectious disease diagnostics, Almi Invest, AstraZeneca, Bayer, Beactica, Big Pharma, BioGeneration Ventures, Biotechnology, BluSense Diagnostics, Boehringer Ingelheim, Bristol-Mayer Squibb, DNB, EIC pilot, European Innovation Council pilot, GE Healthcare, Gilde Healthcare, Gimv, global pharmaceutical companies, HealthCap, IBM, Industrifonden, Investors, IQVIA, Johnson & Johnson Innovation, Jonas Ekstrand, Lundbeckfonden Ventures, medical technology to diagnostics, MSD, NLSDays, Nordic Life Science Days, Nordic Stars 2018 Award, Northern Europe, Novo, Optomed, Pfizer, Pharmaceutical, Roche, Sanofi, Seventure Partners, SOBI, Stockholm, SwedenBIO, Swedish life science industry organization

The highly coveted award was presented to the winners from three Nordic countries at the conclusion of the Nordic Life Science Days (NLSDays) in Stockholm.